Nanobody: A Small Antibody with Big Implications for Tumor Therapeutic Strategy

The development of monoclonal antibody treatments for successful tumor-targeted therapies took several decades. However, the efficacy of antibody-based therapy is still confined and desperately needs further improvement. Nanobodies are the recombinant variable domains of heavy-chain-only antibodies,...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Int J Nanomedicine
Autors principals: Sun, Shuyang, Ding, Ziqiang, Yang, Xiaomei, Zhao, Xinyue, Zhao, Minlong, Gao, Li, Chen, Qu, Xie, Shenxia, Liu, Aiqun, Yin, Shihua, Xu, Zhiping, Lu, Xiaoling
Format: Artigo
Idioma:Inglês
Publicat: Dove 2021
Matèries:
Review
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7997558/
https://ncbi.nlm.nih.gov/pubmed/33790553
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IJN.S297631
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars